Minimising time to treatment: targeted strategies to minimise time to thrombolysis for acute ischaemic stroke

被引:15
|
作者
Tai, Y. J. [1 ]
Yan, B. [1 ]
机构
[1] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med, Parkville, Vic 3050, Australia
关键词
acute stroke; emergency; IV-tPA; stroke protocol; EARLY MANAGEMENT; CODE ACTIVATION; CARE; ALTEPLASE; GUIDELINES; SYMPTOMS; PROTOCOL; OUTCOMES; MINUTES; DELAY;
D O I
10.1111/imj.12204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Time to thrombolysis is a critical determinant of favourable outcomes in acute ischaemic stroke. It is not infrequent that patient outcomes are compromised due to out-of-hospital and in-hospital time delays. On the other hand, time delays could be minimised through the identification of barriers and the implementation of targeted solutions. This review outlines the different strategies in minimising treatment delays and offers recommendations. Literature search in PubMed, Medline and EBSCO Host was conducted to identify studies that are relevant to reduction of time to treatment from January 1995 to December 2012. Strategies to reduce time to thrombolysis are categorised into pre-hospital strategies, in-hospital strategies and post-treatment decision strategies. Proposed pre-hospital strategies include public education on stroke symptoms awareness, prioritising stroke by emergency medical services, increasing ease of access to medical records, pre-hospital notification, and mobile computed tomography scanning. In-hospital strategies include a streamlined code stroke system, computed tomography scanner co-location with emergency department, 24/7 availability of stroke physicians, point-of-care laboratory testing and access to expert neuroimaging interpretation. Post-decision strategies include increasing availability of intravenous thrombolysis and simplification of informed consent procurement. Time to thrombolysis delays is multifactorial. Effective reduction of time delays for acute ischaemic stroke requires the correct identification of and targeted strategies to overcome time barriers.
引用
收藏
页码:1176 / 1182
页数:7
相关论文
共 50 条
  • [21] Thrombolysis in acute ischaemic stroke: an update
    Zaheer, Zahid
    Robinson, Thompson
    Mistri, Amit K.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (02) : 119 - 131
  • [22] Timeframe for thrombolysis in acute ischaemic stroke
    Tsivgoulis, Georgios
    Alexandrov, Andrei V.
    LANCET, 2008, 372 (9646): : 1275 - 1276
  • [23] Reply: Thrombolysis in acute ischaemic stroke
    Balami, Joyce S.
    Hadley, Gina
    Sutherland, Brad A.
    Karbalai, Hasneen
    Buchan, Alastair M.
    BRAIN, 2014, 137 : E82 - E82
  • [24] Barriers to Thrombolysis in Acute Ischaemic Stroke
    Sreedharan, Sapna Erat
    Jeffries, William
    Vale, Elizabeth
    Ravindran, Janakan
    NEUROLOGY, 2010, 74 (09) : A345 - A346
  • [25] Systemic thrombolysis for acute ischaemic stroke
    Leys, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 646 - 646
  • [26] Thrombolysis and thrombectomy for acute ischaemic stroke
    El Tawil, Salwa
    Muir, Keith W.
    CLINICAL MEDICINE, 2017, 17 (02) : 161 - 165
  • [27] THROMBOLYSIS IN ACUTE ISCHAEMIC STROKE Cochrane reviewers' response to Alper and colleagues' analysis of thrombolysis in acute ischaemic stroke
    Wardlaw, Joanna
    Berge, Eivind
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [28] Thrombolysis in the treatment of acute ischaemic stroke - What are the likely pharmacoeconomic consequences?
    Lindsberg, PJ
    Roine, RO
    Kaste, M
    CNS DRUGS, 2000, 14 (01) : 1 - 9
  • [29] Successful intravenous thrombolysis in acute ischaemic stroke in a patient on rivaroxaban treatment
    Maciej Kawiorski, Michal
    Alonso-Canovas, Araceli
    de Felipe Mimbrera, Alicia
    Sainz de la Maza, Susana
    Alvarez-Velasco, Rodrigo
    Zarza, Beatriz
    Masjuan, Jaime
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (03) : 557 - 558
  • [30] Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over time
    Dequatre-Ponchelle, N.
    Touzani, H.
    Banh, A.
    Girard-Buttaz, I.
    Coche, R.
    Dobbelaere, P.
    Cordonnier, C.
    Girot, M.
    Aguettaz, P.
    Mounier-Vehier, F.
    Wiel, E.
    Bronet, N.
    Josien, E.
    Duhamel, P.
    Mihout, M.
    Maisonneuve, A.
    Mackowiak, A.
    Bodenant, M.
    Williatte, P.
    Leclerc, X.
    Lefebvre, C.
    Nigeon, O.
    Devos, P.
    Duncan, G.
    Malanda, G.
    Majed, B.
    Dereeper, O.
    Pegoraro, V.
    Rosolacci, T.
    Alarcon, P.
    Koral, E.
    Pasquini, M.
    Verclytte, S.
    N'Kuendjo, J. B.
    Campagne, J. B.
    Le Coz, P.
    Devienne, J.
    Seth, Z.
    Tholliez, R.
    Henon, H.
    Smith, G.
    Dumont, F.
    Agbemebia, F.
    Behra, J. M.
    Pollet, D.
    Coffin, P.
    Lavau, P.
    Verier, A.
    Lucas, C.
    Smaiti, N.
    JOURNAL OF NEUROLOGY, 2014, 261 (07) : 1320 - 1328